J
Jill M. Ferdinands
Researcher at Centers for Disease Control and Prevention
Publications - 80
Citations - 3679
Jill M. Ferdinands is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Influenza vaccine & Vaccination. The author has an hindex of 23, co-authored 68 publications receiving 1880 citations. Previous affiliations of Jill M. Ferdinands include Battelle Memorial Institute.
Papers
More filters
Journal ArticleDOI
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Jill M. Ferdinands,S. Rao,Brian E. Dixon,Patrick K. Mitchell,Malini B. DeSilva,Stephanie A. Irving,Ned Lewis,Karthik Natarajan,Edward Stenehjem,Shaun J. Grannis,Jungmi Han,Charlene McEvoy,Toan C. Ong,Allison L. Naleway,Sara E. Reese,Peter J. Embi,Kristin Dascomb,Nicola P. Klein,E. Griggs,D. Konatham,Anupam B. Kharbanda,Duck-Hye Yang,William F. Fadel,Nancy Grisel,Kristin Goddard,Palak Patel,I-Chia Liao,Rebecca Birch,Nimish Valvi,Sue Reynolds,Julie Arndorfer,Ousseny Zerbo,M. Dickerson,Kempapura Murthy,Jeremiah Williams,Catherine H Bozio,Lenee Blanton,Jennifer R. Verani,Stephanie J. Schrag,Alexandra F. Dalton,Mehiret Wondimu,Ruth Link-Gelles,Eduardo Azziz-Baumgartner,Michelle A. Barron,Manjusha Gaglani,Mark Thompson,Bruce Fireman +46 more
TL;DR: VE after receipt of a third dose was higher than that after a second dose; however, VE waned with increasing time since vaccination, and VE was generally higher for protection against hospitalizations than against ED/UC visits.
Journal ArticleDOI
Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.
Mark G. Thompson,Edward Stenehjem,Shaun J. Grannis,Sarah Ball,Allison L. Naleway,Toan C. Ong,Malini B. DeSilva,Karthik Natarajan,Catherine H Bozio,Ned Lewis,Kristin Dascomb,Brian E. Dixon,Rebecca J. Birch,Stephanie A. Irving,Suchitra Rao,Elyse O. Kharbanda,Jungmi Han,Sue Reynolds,Kristin Goddard,Nancy Grisel,William F. Fadel,Matthew E Levy,Jill M. Ferdinands,Bruce Fireman,J.A Arndorfer,Nimish R. Valvi,Elizabeth A Rowley,Palak Patel,Ousseny Zerbo,Eric P. Griggs,Rachael M. Porter,Maria Demarco,Lenee Blanton,Andrea Steffens,Yan Zhuang,Natalie Olson,Michelle A. Barron,Pat Shifflett,Stephanie J. Schrag,Jennifer R. Verani,Alicia M Fry,Manjusha Gaglani,Eduardo Azziz-Baumgartner,Nicola P. Klein +43 more
TL;DR: In this article, the effectiveness of the Ad26.COV2.S vaccine against SARS-CoV-2 infection requiring hospitalization, ICU admission, or an emergency department or urgent care clinic visit was evaluated.
Journal ArticleDOI
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Mark Thompson,Karthik Natarajan,Stephanie A. Irving,Elizabeth Rowley,E. Griggs,Manjusha Gaglani,Nicola P. Klein,Shaun J. Grannis,Malini B. DeSilva,Edward Stenehjem,Sara E. Reese,M. Dickerson,Allison L. Naleway,Jungmi Han,D. Konatham,Charlene McEvoy,S. Rao,Brian E. Dixon,Kristin Dascomb,Ned Lewis,M. Levy,Palak Patel,I-Chia Liao,Anupam B. Kharbanda,Michelle A. Barron,William F. Fadel,Nancy Grisel,Kristin Goddard,Duck-Hye Yang,Mehiret Wondimu,Kempapura Murthy,Nimish Valvi,Julie Arndorfer,Bruce Fireman,M. Dunne,Peter J. Embi,Eduardo Azziz-Baumgartner,Ousseny Zerbo,Catherine H Bozio,Sue Reynolds,Jill M. Ferdinands,Jeremiah Williams,Ruth Link-Gelles,Stephanie J. Schrag,Jennifer R. Verani,Sarah Ball,Toan C. Ong +46 more
TL;DR: The highest estimates of VE against COVID-19-associated ED and UC encounters or hospitalizations during both Delta- and Omicron-predominant periods were among adults who received a third dose of mRNA vaccine, and all unvaccinated persons should get vaccinated as soon as possible.
Journal ArticleDOI
The case test-negative design for studies of the effectiveness of influenza vaccine.
TL;DR: Under sets of increasingly general assumptions, it is found that the case test-negative design can provide unbiased VE estimates, but if vaccinated cases are less severely ill and seek care less frequently than unvaccinated cases, then an appropriate adjustment for illness severity is required to avoid bias in effectiveness estimates.
Journal ArticleDOI
Acute health effects after exposure to chlorine gas released after a train derailment.
David Van Sickle,Mary Anne Wenck,Mary Anne Wenck,Amy Belflower,Dan Drociuk,Jill M. Ferdinands,Fernando Holguin,Fernando Holguin,Erik R. Svendsen,Erik R. Svendsen,Lena Bretous,Shirley Jankelevich,James J. Gibson,Paul Garbe,Ronald L. Moolenaar +14 more
TL;DR: Hypoxia on room air and PO2/FiO2 ratio predicted severity of outcome as assessed by the duration of hospitalization and the need for intensive care support.